AryaTinaGene

AryaTinaGene is a prominent Iranian biopharmaceutical company specializing in the development and large-scale manufacture of high-quality biosimilar products. Founded in 2005 and headquartered in Gorgan, the company focuses on critical therapeutic areas including oncology, hematology, and autoimmune diseases. Its commercial portfolio features advanced biologics such as biosimilar versions of Trastuzumab, Rituximab, and Filgrastim. AryaTinaGene operates sophisticated GMP-certified facilities capable of handling the entire production process from cell line development to final fill-and-finish. The company is a key contributor to the regional biotechnology landscape, aiming to provide affordable access to life-saving biological therapies in Iran and neighboring markets.